This is the list of Geron's Scientific Advisory Board and
consultants copied from the company's most recent 10K.
With people like James Watson (Nobel Laureate and co-discoverer
of the DNA double-helix), Leonard Hayflick (the "father" of
cellular gerontology) and Elizabeth Blackburn and Carol Greider
(co-discoverers of telomerase), I believe it's one of the most
impressive listings of scientific collaborators in the biotech
industry.
ELIZABETH BLACKBURN, PH.D., is a Professor and Chair of the
Department of Microbiology and Immunology at the University of
California at San Francisco and a member of the National Academy
of Sciences. Dr. Blackburn is known for her pioneering
characterization of telomeres and for her co-discovery of
telomerase with Dr. Carol Greider in 1985 and subsequent
characterization of this important enzyme.
GUNTER K. BLOBEL, M.D., PH.D., is an investigator at the
Howard Hughes Medical Institute, Rockefeller University and is a
member of the Company's SAB. Dr. Blobel is a member of the
National Academy of Sciences, the recipient of the 1993 Lasker
Award and past president of the American Society for Cell
Biology. He is well known for his work in protein translocation
and is now turning much of his research focus to nuclear
trafficking.
DAVID BOTSTEIN, PH.D., is Professor and Chairman of the
Department of Genetics, Stanford University School of Medicine.
He was elected to the National Academy of Sciences in 1981 and to
the Institute of Medicine in 1993. His current research
activities include studies of yeast genetics and cell biology and
linkage mapping of human genes predisposing to manic-depressive
illness and the development and maintenance of the Saccharomyces
Genome Database on the World Wide Web. He has received numerous
awards, including the Eli Lilly Award in Microbiology (1978), the
Genetics Society of America Medal (1985), and the Allen Award of
the American Society of Human Genetics (1989). Dr. Botstein has
served on numerous committees including the NAS/NRC study on the
Human Genome Project (1987-88), the NIH Program Advisory Panel on
the Human Genome (1989-90) and the Advisory Council of the
National Center for Human Genome Research (1990-1995).
ROBERT N. BUTLER, M.D., is a gerontologist and psychiatrist
with broad experience in aging research and advocacy. In 1982, he
founded the first, and still the only, department of geriatrics
at a United States medical school -- the Department of Geriatrics
and Adult Development at the Mount Sinai Medical Center -- where
he continues to serve as Professor. Since 1990, he has also been
Director of the International Longevity Centers. In 1975, he
became the founding director of the National Institute on Aging
of the National Institutes of Health, a position he held until
1982. He currently serves on the National Advisory Council of the
National Institute on Aging. Dr. Butler also serves as
editor-in-chief of the journal Geriatrics and is the author of
approximately 300 scientific and medical articles. In 1976, he
won the Pulitzer Prize for his book, "Why Survive? Being Old in
America."
JUDITH CAMPISI, PH.D., is a Senior Scientist and Acting Chair,
Department of Cancer Biology, Lawrence Berkeley National
Laboratory. She has been an Established Investigator of the
American Heart Association and currently has a MERIT Award from
the National Institute on Aging, and serves on the NIA Board of
Scientific Counselors. Her major interest is the cellular and
molecular biology of senescence and tumorigenesis.
VINCENT CRISTOFALO, PH.D., is a Professor of Pathology and
Laboratory Medicine, and Director of the Center for
Gerontological Research, Medical College of Pennsylvania and
Hahnemann University and is a member of the Company's SAB. In
addition, he is professor emeritus at the University of
Pennsylvania and adjunct professor at the Wistar Institute. He
sits on the Board of Scientific Counselors of the National
Institute on Aging and the Department of Veterans Affairs
Geriatrics and Gerontology Advisory Committee, as well as
numerous editorial boards.
JOHN GEARHART, PH.D., is a Professor of Gynecology and
Obstetrics, Physiology, Comparative Medicine, and Population
Dynamics at the School of Medicine of Johns Hopkins University,
where he is also the Director of the Division of Genetics and the
Preimplantation Genetics Diagnosis Program. Dr. Gearhart has been
a leader in the utilization of transgenic models and in the
development of new transgenic and embryonic stem cell
technologies.
CAROL GREIDER, PH.D., is a Senior Staff Scientist at the Cold
Spring Harbor Laboratory and is a member of the Company's SAB.
She is known for her co-discovery of telomerase with Dr.
Elizabeth Blackburn. Her pioneering work on the molecular
mechanisms of this enzyme and its role in cellular
immortalization is widely recognized.
LEONARD GUARANTE, PH.D., has studied mechanisms of eukaryotic
transcriptional regulation over the past 17 years. More recently,
his lab has turned its focus to identifying causes of aging by
identifying genes that control lifespan in the model system S.
cerevisiae. His lab has also begun a study of the WRN gene,
mutations in which give rise to Werner's Syndrome, a human
disease characterized by premature aging.
DOUGLAS HANAHAN, PH.D., is a Professor of Biochemistry in the
Department of Biochemistry and Biophysics and Associate Director
of the Hormone Research Institute, University of California at
San Francisco ("UCSF") and is a member of the Company's SAB. His
major research interests are the cellular and genetic mechanisms
of tumor development and autoimmunity. Prior to joining UCSF in
1988, Dr. Hanahan was with the Cold Spring Harbor Laboratory for
nine years, where he developed technologies for recombinant DNA
and molecular cloning and established transgenic mouse models to
study cancer and autoimmune diseases.
LEONARD HAYFLICK, PH.D., is a Professor of Anatomy at the
School of Medicine of the University of California at San
Francisco, and is a member of the Company's SAB. Dr. Hayflick is
best known for his pioneering work in tissue culture, where he
discovered the finite replicative capacity of normal human cells
which he interpreted as aging at the cellular level. This
phenomenon is known as the "Hayflick Limit" and Dr. Hayflick is
widely known as the "father" of cellular gerontology. Dr.
Hayflick has published over 200 papers and is the recipient of
numerous national and international research awards and honors,
was President of the Gerontological Society of America, is
editor-in-chief of Experimental Gerontology, was a founding
member of the Council of the National Institute on Aging, and
recently authored the popular book, "How and Why We Age."
ERIC LANDER, PH.D., is a Professor of Biology at the
Massachusetts Institute of Technology and serves as the Director
of the Whitehead Institute/MIT Center for Genome Research. Dr.
Lander is active in several organizations involved in human
genetics research, including serving on the board of directors
for the Genetic Society of America, acting as former chair of the
Genome Research Review Committee for NIH's National Center for
Human Genome Research and is a member of the Company's SAB. He
brings broad experience in human and mammalian genetic research.
GEORGE M. MARTIN, M.D., is Professor of Pathology, Adjunct
Professor of Genetics and Director of Alzheimer's Disease
Research Center, University of Washington School of Medicine. He
has held various positions in the departments of pathology and
genetics at the University of Washington School of Medicine since
1957, and was appointed director of the Alzheimer's Disease
Research Center in 1985. Dr. Martin's recent awards include a
Research Medal granted by the American Aging Association in 1992
and the Robert W. Kleemeier Award given by the Gerontological
Society of America in 1993.
MALCOLM MOORE, PH.D., is a Professor of Biology at the
Sloan-Kettering Division, Cornell Graduate School of Medical
Sciences. He is also currently incumbent of the Enid A. Haupt
Chair of Cell Biology, Memorial Sloan-Kettering Cancer Center.
Dr. Moore most recently received the William B. Coley Award For
Distinguished Research in Immunology by the Cancer Research
Institute (June 1995).
ROGER A. PEDERSEN, PH.D., is a Professor of Obstetrics,
Gynecology and Reproductive Sciences at the University of
California at San Francisco, where he teaches developmental
genetics and mammalian embryology. He received his B.A. degree
from Stanford University in 1965, and his Ph.D. in 1970 at Yale
University. He completed his postdoctoral research at the Johns
Hopkins University. Since 1991 he has served as Series Editor of
Current Topics in Developmental Biology. He has written numerous
original publications and reviews on early mouse development, and
co-produced two instructional videotapes on the use of mice in
transgenic and gene targeting research.
JERRY W. SHAY, PH.D., is a Professor of Cell Biology and
Neuroscience, the University of Texas Southwestern Medical Center
at Dallas and is a member of the Company's SAB. Dr. Shay's
research focuses on molecular mechanisms of tumorigenesis and
immortalization with a particular emphasis on cancer of the
breast.
JAMES D. WATSON, PH.D., is the President of Cold Spring Harbor
Laboratory and is a member of the Company's SAB. Dr. Watson is
the former head of the NIH Human Genome Project and is famous for
his 1953 discovery with Francis Crick of the double helical
structure of DNA for which he received the Nobel Prize.
WOODRING E. WRIGHT, M.D., PH.D., is a Professor of Cell
Biology and Neuroscience, the University of Texas Southwestern
Medical Center at Dallas and is a member of the Company's SAB. He
is widely recognized as a leading molecular biologist working in
the field of cellular senescence and on the molecular basis of
muscle development. |
